SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wiese Edward A

(Last)

(First)

(Middle)

T. ROWE PRICE GROUP, INC.

100 E. PRATT STREET

(Street)

BALTIMORE

21202

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2015

3. Issuer Name and Ticker or Trading Symbol
PRICE T ROWE GROUP INC [ TROW ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	140,640.301	D
Common Stock	12,281	I	Spouse
Common Stock	76,000.277	I	Wiese EA Family 2012 Trust
Common Stock	38,000	I	Wiese RJ Family 2012 Trust
Common Stock	38,000	I	Wiese WS Family 2012 Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	⁽¹⁾	10/03/2015	Common Stock	3,046	$32.118	D
Stock Options (Right to Buy)	⁽²⁾	11/01/2016	Common Stock	10,155	$45.4792	D
Stock Options (Right to Buy)	⁽³⁾	09/06/2017	Common Stock	8,124	$49.2503	D
Stock Options (Right to Buy)	⁽⁴⁾	09/04/2018	Common Stock	7,109	$56.2017	D
Stock Options (Right to Buy)	⁽⁵⁾	02/12/2019	Common Stock	1,645	$27.0473	D
Stock Options (Right to Buy)	⁽⁶⁾	09/10/2019	Common Stock	4,061	$44.4552	D
Stock Options (Right to Buy)	⁽⁷⁾	02/18/2020	Common Stock	6,092	$48.8368	D
Stock Options (Right to Buy)	⁽⁸⁾	09/08/2020	Common Stock	6,093	$46.9365	D
Stock Options (Right to Buy)	⁽⁹⁾	02/17/2021	Common Stock	6,093	$69.2478	D
Stock Options (Right to Buy)	⁽¹⁰⁾	09/08/2021	Common Stock	6,092	$49.7721	D
Stock Options (Right to Buy)	⁽¹¹⁾	02/23/2022	Common Stock	3,046	$60.5438	D
Stock Options (Right to Buy)	⁽¹²⁾	09/06/2022	Common Stock	3,046	$62.3161	D
Stock Options (Right to Buy)	⁽¹³⁾	02/21/2023	Common Stock	3,000	$71.41	D
Stock Options (Right to Buy)	⁽¹⁴⁾	09/10/2023	Common Stock	3,000	$72.04	D
Stock Options (Right to Buy)	⁽¹⁵⁾	02/19/2024	Common Stock	3,000	$79.89	D
Stock Options (Right to Buy)	⁽¹⁶⁾	09/09/2024	Common Stock	3,000	$80.4	D

Explanation of Responses:

1. 10/03/2005 Grant - The option vests 20% annually over a 5 year period beginning on 10/03/2006.

2. 11/01/2006 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2007.

3. 09/06/2007 Grant - The option vests 20% annually over a 5 year period beginning on 09/06/2008.

4. 09/04/2008 Grant - The option vests 20% annually over a 5 year period beginning on 09/04/2009.

5. 02/12/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.

6. 09/10/2009 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2010.

7. 02/18/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.

8. 09/08/2010 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2011.

9. 02/17/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.

10. 09/08/2011 Grant - The option vests 20% annually over a 5 year period beginning on 11/01/2012.

11. 02/23/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.

12. 09/06/2012 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2013.

13. 02/21/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.

14. 09/10/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.

15. 02/19/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.

16. 09/09/2014 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2015.

	Edward A. Wiese	01/27/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.